Vancomycin Pretreatment on MPTP-Induced Parkinson’s Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and Gut
The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
A growing body of evidence implies that gut microbiota was involved in pathogenesis of Parkinson's disease (PD), but the mechanism is still unclear. The aim of this study is to investigate the effects of antibiotics pretreatment on the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced PD mice. In this study, vancomycin pretreatment was given by gavage once daily with either vancomycin or distilled water for 14 days to mice, then mice were administered with MPTP (20 mg/kg, i.p) for four times in one day to establish an acute PD model. Results show that vancomycin pretreatment significantly improved motor dysfunction of mice in pole and traction tests. Although vancomycin pretreatment had no effect on dopamine (DA) or the process of DA synthesis, it inhibited the metabolism of DA by suppressing the expression of striatal monoamine oxidase B (MAO-B). Furthermore, vancomycin pretreatment reduced the number of astrocytes and microglial cells in the substantia nigra pars compacta (SNpc) to alleviate neuroinflammation, decreased the expression of TLR4/MyD88/NF-κB/TNF-α signaling pathway in both brain and gut. Meanwhile, vancomycin pretreatment changed gut microbiome composition and the levels of fecal short chain fatty acids (SCFAs). The abundance of Akkermansia and Blautia increased significantly after vancomycin pretreatment, which might be related to inflammation and inhibition of TLR4 signaling pathway. In summary, these results demonstrate that the variation of gut microbiota and its metabolites induced by vancomycin pretreatment might decrease dopamine metabolic rate and relieve inflammation in both gut and brain via the microbiota-gut-brain axis in MPTP-induced PD mice. The neuroprotection of vancomycin pretreatment on MPTP-induced Parkinson's disease mice The alterations of gut microbiota and SCFAs induced by vancomycin pretreatment might not only improve motor dysfunction, but also decrease dopamine metabolism and relieve inflammation in both brain and gut via TLR4/MyD88/NF-κB/TNF-α pathway in MPTP-induced PD mice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cui et al. reported that vancomycin pretreatment of MPTP-induced PD mice improved motor symptoms by reducing SN astrocytes and microglia activation [218]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [218]
Citations
Cites
Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy
Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 19,885 · cited 1×
“The representative sequences were classified into organisms by a naive Bayesian model using RDP classifier (Wang et al. 2007) (version 2.”
MethodUPARSE: highly accurate OTU sequences from microbial amplicon reads
Edgar, R. C. (2013) · Nature Methods · doi:10.1038/nmeth.2604 · Cited by 16,707
Pruesse, E., Quast, C., Knittel, K., Fuchs, B. M., Ludwig, W., Peplies, J., & Glockner, F. O. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm864 · Cited by 6,668 · cited 2×
“2007) (version 2.2) based on SILVA (Pruesse et al.”
MethodInfluentialCross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511 · cited 1×
“Interestingly, the most prominently upregulated genus in the Verrucomicrobia phylum was Akkermansia after vancomycin pretreatment, which plays an important role in mucin degradation and is negatively correlated with proinflammatory cytokines and chemokines in several animal models of disease (Everard et al. 2013; Ring…”
BackgroundGut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Gut microbiota, metabolites and host immunity
Rooks, M. G., & Garrett, W. S. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2016.42 · Cited by 3,409
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., et al. (2013) · Nature · doi:10.1038/nature12331 · Cited by 2,872
Interactive metagenomic visualization in a Web browser
Ondov, B. D., Bergman, N. H., & Phillippy, A. M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-385 · Cited by 2,144
Gut microbiome structure and metabolic activity in inflammatory bowel disease
Franzosa, E. A., Sirota-Madi, A., Avila-Pacheco, J., Fornelos, N., Haiser, H. J., Reinker, S., Vatanen, T., Hall, A. B., Mallick, H., McIver, L. J., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0306-4 · Cited by 1,995
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968 · cited 2×
“Benefiting from the accumulated studies about gut-brain axis, intestinal microbiota and its metabolites has been found to participate in the pathogenetic process of PD (Scheperjans et al. 2015; Li et al. 2017).”
Background
Cited by
Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88
Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
Ma, Y., Li, X., Yu, J., & Wang, Y. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00404-1 · Cited by 104
“Antibiotics have also been found to significantly improve motor dysfunction and alleviate neuroinflammation by increasing the relative abundance of Akkerman-sia and Lachnospiraceae and SCFA levels in the faeces of MPTP-induced and transgenic PD mouse models [172– 174].”
BackgroundA prebiotic diet modulates microglial states and motor deficits in α-synuclein overexpressing mice
Abdel-Haq, R., Schlachetzki, J. C., Boktor, J. C., Cantu-Jungles, T. M., Thron, T., Zhang, M., Bostick, J. W., Khazaei, T., Chilakala, S., Morais, L. H., et al. (2022) · eLife · doi:10.7554/elife.81453 · Cited by 82
“Additionally, antibiotic treatment improves motor symptoms in several models of PD (Cui et al. 2022; Pu et al. 2019; Sampson et al. 2016).”
BackgroundMahbub, N. U., Islam, M. M., Hong, S., & Chung, H. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1348279 · Cited by 97
Qiao, C.-M., Huang, W., Zhou, Y., Quan, W., Niu, G.-Y., Li, T., Zhang, M.-X., Wu, J., Zhao, L., Zhao, W.-J., et al. (2024) · Brain Sciences · doi:10.3390/brainsci14030238 · Cited by 66
“Recent studies have shown a strong correlation between gut inflammation and gut microbiota dysbiosis, which are involved in the gut-brain axis and the development of PD [6,7,16,23,36].”
BackgroundResultSelf-citation
Metadata
- Authors
- Cui, C., Hong, H., Shi, Y., Zhou, Y., Qiao, C.-M., Zhao, W.-J., Zhao, L.-P., Wu, J., Quan, W., Niu, G.-Y., Wu, Y.-B., Li, C.-S., Cheng, L., Hong, Y., & Shen, Y.-Q.
- Affiliations
- Jiangnan University (CN)
- Wuxi Fourth People's Hospital (CN)
- Corresponding author
- Shen, Yan-Qin
- ORCID
- Venue
- Journal of Neuroimmune Pharmacology
- Published
- 2022-01-29
- Volume
- 18
- Issue
- 1-2
- Pages
- 72-89
- ISSN
- 1557-1890 (ISSN-L)
- 1557-1904
- OpenAlex
- W4210609396
- Cited by
- 45
- References
- 60
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 10 · 2023: 13 · 2022: 2
- FWCI
- 5.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Journal of Neuroimmune Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81771384, 81801276, 82171429)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, MPTP-induced neurotoxicity, gut microbiota, microbiota-gut-brain axis, neuroinflammation, dopamine metabolism, monoamine oxidase B, short-chain fatty acids, Akkermansia, Blautia, substantia nigra pars compacta, motor impairment, neuroprotection
- MeSH terms
- Neuroprotection, Animals, Brain, Disease Models, Animal, Dopamine, Inflammation, Mice, Inbred C57BL, Parkinson Disease, Tumor Necrosis Factor-alpha, Vancomycin, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, NF-kappa B, Neuroprotective Agents, Toll-Like Receptor 4, Mice, Myeloid Differentiation Factor 88
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vancomycin Pretreatment on MPTP-Induced Parkinson’s Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and Gut. https://app.cochat.ai/papers/10.1007/s11481-021-10047-y
- The paper
- Cui, C., Hong, H., Shi, Y., Zhou, Y., Qiao, C.-M., Zhao, W.-J., Zhao, L.-P., Wu, J., Quan, W., Niu, G.-Y., Wu, Y.-B., Li, C.-S., Cheng, L., Hong, Y., & Shen, Y.-Q. (2023). Vancomycin Pretreatment on MPTP-Induced Parkinson’s Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and Gut. Journal of Neuroimmune Pharmacology. https://doi.org/10.1007/s11481-021-10047-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.